Devonian Health Group Stock Net Income
| GSD Stock | CAD 10.00 1.50 13.04% |
As of the 9th of February, Devonian Health shows the Mean Deviation of 177.69, downside deviation of 34.07, and Coefficient Of Variation of 825.07. Devonian Health Group technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Devonian Health Group information ratio, value at risk, as well as the relationship between the Value At Risk and expected short fall to decide if Devonian Health Group is priced favorably, providing market reflects its regular price of 10.0 per share.
Devonian Health Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization 27.7 M | Enterprise Value Revenue 1.1407 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -5.4 M | -5.1 M | |
| Net Loss | -3.1 M | -3.3 M | |
| Net Loss | -5.4 M | -5.1 M |
Devonian | Net Income |
The evolution of Net Income for Devonian Health Group provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Devonian Health compares to historical norms and industry peers.
Latest Devonian Health's Net Income Growth Pattern
Below is the plot of the Net Income of Devonian Health Group over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Devonian Health Group financial statement analysis. It represents the amount of money remaining after all of Devonian Health Group operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Devonian Health's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Devonian Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (6.01 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Devonian Net Income Regression Statistics
| Arithmetic Mean | (2,690,472) | |
| Coefficient Of Variation | (79.87) | |
| Mean Deviation | 1,879,034 | |
| Median | (3,187,068) | |
| Standard Deviation | 2,149,005 | |
| Sample Variance | 4.6T | |
| Range | 5.8M | |
| R-Value | (0.84) | |
| Mean Square Error | 1.4T | |
| R-Squared | 0.71 | |
| Significance | 0.000021 | |
| Slope | (358,825) | |
| Total Sum of Squares | 73.9T |
Devonian Net Income History
Devonian Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Devonian Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Devonian Health.
| 11/11/2025 |
| 02/09/2026 |
If you would invest 0.00 in Devonian Health on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding Devonian Health Group or generate 0.0% return on investment in Devonian Health over 90 days. Devonian Health is related to or competes with Primaris Retail, East Side, MTY Food, Data Communications, Verizon Communications, Element Fleet, and Maple Leaf. Devonian Health Group Inc., a pharmaceutical company, engages in the development of botanical drugs More
Devonian Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Devonian Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Devonian Health Group upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 34.07 | |||
| Information Ratio | 0.1211 | |||
| Maximum Drawdown | 5952.63 | |||
| Value At Risk | (11.76) | |||
| Potential Upside | 8.57 |
Devonian Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Devonian Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Devonian Health's standard deviation. In reality, there are many statistical measures that can use Devonian Health historical prices to predict the future Devonian Health's volatility.| Risk Adjusted Performance | 0.1076 | |||
| Jensen Alpha | 96.35 | |||
| Total Risk Alpha | 16.36 | |||
| Sortino Ratio | 2.61 | |||
| Treynor Ratio | (0.94) |
Devonian Health February 9, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1076 | |||
| Market Risk Adjusted Performance | (0.93) | |||
| Mean Deviation | 177.69 | |||
| Semi Deviation | 10.11 | |||
| Downside Deviation | 34.07 | |||
| Coefficient Of Variation | 825.07 | |||
| Standard Deviation | 733.01 | |||
| Variance | 537310.83 | |||
| Information Ratio | 0.1211 | |||
| Jensen Alpha | 96.35 | |||
| Total Risk Alpha | 16.36 | |||
| Sortino Ratio | 2.61 | |||
| Treynor Ratio | (0.94) | |||
| Maximum Drawdown | 5952.63 | |||
| Value At Risk | (11.76) | |||
| Potential Upside | 8.57 | |||
| Downside Variance | 1160.65 | |||
| Semi Variance | 102.23 | |||
| Expected Short fall | (754.87) | |||
| Skewness | 8.12 | |||
| Kurtosis | 65.95 |
Devonian Health Group Backtested Returns
Devonian Health is out of control given 3 months investment horizon. Devonian Health Group secures Sharpe Ratio (or Efficiency) of 0.12, which denotes the company had a 0.12 % return per unit of risk over the last 3 months. We were able to interpolate twenty-six different technical indicators, which can help you to evaluate if expected returns of 14.88% are justified by taking the suggested risk. Use Devonian Health Coefficient Of Variation of 825.07, downside deviation of 34.07, and Mean Deviation of 177.69 to evaluate company specific risk that cannot be diversified away. Devonian Health holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -94.34, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Devonian Health are expected to decrease by larger amounts. On the other hand, during market turmoil, Devonian Health is expected to outperform it. Use Devonian Health value at risk, as well as the relationship between the expected short fall and day median price , to analyze future returns on Devonian Health.
Auto-correlation | -0.17 |
Insignificant reverse predictability
Devonian Health Group has insignificant reverse predictability. Overlapping area represents the amount of predictability between Devonian Health time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Devonian Health Group price movement. The serial correlation of -0.17 indicates that over 17.0% of current Devonian Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.17 | |
| Spearman Rank Test | -0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 4.12 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Devonian Operating Income
Operating Income |
|
Based on the recorded statements, Devonian Health Group reported net income of (6.01 Million). This is 101.76% lower than that of the Biotechnology sector and 108.58% lower than that of the Health Care industry. The net income for all Canada stocks is 101.05% higher than that of the company.
Devonian Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Devonian Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Devonian Health could also be used in its relative valuation, which is a method of valuing Devonian Health by comparing valuation metrics of similar companies.Devonian Health is currently under evaluation in net income category among its peers.
Devonian Fundamentals
| Return On Equity | -0.6 | ||||
| Return On Asset | -0.0459 | ||||
| Profit Margin | (0.38) % | ||||
| Operating Margin | (1.51) % | ||||
| Current Valuation | 21.13 M | ||||
| Shares Outstanding | 2.77 M | ||||
| Shares Owned By Insiders | 12.50 % | ||||
| Number Of Shares Shorted | 156 | ||||
| Price To Book | 2.88 X | ||||
| Price To Sales | 1.49 X | ||||
| Revenue | 23.59 M | ||||
| Gross Profit | 7.11 M | ||||
| EBITDA | (1.54 M) | ||||
| Net Income | (6.01 M) | ||||
| Cash And Equivalents | 413.87 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 6.69 M | ||||
| Debt To Equity | 43.00 % | ||||
| Current Ratio | 0.95 X | ||||
| Book Value Per Share | 3.47 X | ||||
| Cash Flow From Operations | (1.25 M) | ||||
| Short Ratio | 0.03 X | ||||
| Earnings Per Share | (2.76) X | ||||
| Beta | 1.4 | ||||
| Market Capitalization | 27.66 M | ||||
| Total Asset | 15.83 M | ||||
| Retained Earnings | (33.27 M) | ||||
| Working Capital | 2.11 M | ||||
| Net Asset | 15.83 M |
About Devonian Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Devonian Health Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Devonian Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Devonian Health Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Devonian Stock Analysis
When running Devonian Health's price analysis, check to measure Devonian Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Devonian Health is operating at the current time. Most of Devonian Health's value examination focuses on studying past and present price action to predict the probability of Devonian Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Devonian Health's price. Additionally, you may evaluate how the addition of Devonian Health to your portfolios can decrease your overall portfolio volatility.